Search results
I’m determined to make sure Black women get annual mammograms. Breast cancer is a menace
The Record· 52 minutes agoOver the years, those family trips started to dwindle as eight of my aunts and uncles were overtaken...
Cancer in Canada: Increasing Cases, Decreasing Diagnoses
Medscape· 4 hours agoThe numbers of cancer cases and deaths are rising in Canada, even as overall rates of cancer...
Why early screening is important for prostate health
Rolling Out· 7 days agoProstate health is a crucial aspect of men’s health, yet it often doesn’t receive the attention it deserves. The prostate gland — a small walnut-shaped...
Candel Lights Up Investors' Portfolio With 830% Gain
RTT News· 5 days agoShares of Candel Therapeutics Inc. (CADL) have gained more than 830% in the past 2 months, thanks to the substantial progress achieved across its clinical programs.
Patients Benefit From Advances at Miami Cancer Institute’s Abbhi Family Bladder Cancer Clinic
Miami Herald via Yahoo News· 2 days agoEndowed Chair in Urologic Oncology, who is a renowned leader in the treatment of prostate cancer,...
EDAP shares hold as analyst reiterates $19 target on growth By Investing.com
Investing.com· 4 days agoEDAP's revenue increase is supported by the positive reception of the final data from the HIFI study...
Biomed 2024 Showcases Israel’s Resilient Entrepreneurial Spirit
Forbes· 1 day agoThe need to defend Israeli citizens on multiple fronts for more than seven months has not depressed...
AI may improve doctor–patient interactions for older adults with cancer
Medical Xpress· 6 days agoThen it provides AI-generated information on each option's survival rates, potential side effects and risks, along with links to high-quality online support resources. Initial ...
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
Zacks via Yahoo Finance· 4 days agoPer Amgen, Imdelltra, which is a targeted bispecific therapy, marks a major advancement in the...
Q1 2024 Panbela Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoThis study is actively enrolling. The Phase II eflornithine trial in type 1 diabetes is a multi-center...adenocarcinoma cell lines regardless of their platinum sensitivity. And we found that ...